ペット用ワクチンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Pet Vaccine Market Insights and Forecast to 2028

• レポートコード：QY2203B05943 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のペット用ワクチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にペット用ワクチンの世界市場のxxx％を占める「弱毒生ワクチン」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「犬用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のペット用ワクチンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのペット用ワクチン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのペット用ワクチン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ペット用ワクチンのグローバル主要メーカーには、Bayer Healthcare、Vetoquinol S.A、Boehringer Ingelheim、Ceva、Eli Lilly、Heska Co.、Merck Animal Health、Merial (Sanofi)、Virbac、Zoetis (Pfizer)などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ペット用ワクチン市場は、種類と用途によって区分されます。世界のペット用ワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 弱毒生ワクチン、結合型ワクチン、不活性化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、リコンビナントワクチン 【用途別セグメント】 犬用、鳥用、猫用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ペット用ワクチン製品概要 - 種類別市場（弱毒生ワクチン、結合型ワクチン、不活性化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、リコンビナントワクチン） - 用途別市場（犬用、鳥用、猫用） - 調査の目的 ・エグゼクティブサマリー - 世界のペット用ワクチン販売量予測2017-2028 - 世界のペット用ワクチン売上予測2017-2028 - ペット用ワクチンの地域別販売量 - ペット用ワクチンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ペット用ワクチン販売量 - 主要メーカー別ペット用ワクチン売上 - 主要メーカー別ペット用ワクチン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（弱毒生ワクチン、結合型ワクチン、不活性化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、リコンビナントワクチン） - ペット用ワクチンの種類別販売量 - ペット用ワクチンの種類別売上 - ペット用ワクチンの種類別価格 ・用途別市場規模（犬用、鳥用、猫用） - ペット用ワクチンの用途別販売量 - ペット用ワクチンの用途別売上 - ペット用ワクチンの用途別価格 ・北米市場 - 北米のペット用ワクチン市場規模（種類別、用途別） - 主要国別のペット用ワクチン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのペット用ワクチン市場規模（種類別、用途別） - 主要国別のペット用ワクチン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のペット用ワクチン市場規模（種類別、用途別） - 主要国別のペット用ワクチン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のペット用ワクチン市場規模（種類別、用途別） - 主要国別のペット用ワクチン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのペット用ワクチン市場規模（種類別、用途別） - 主要国別のペット用ワクチン市場規模（トルコ、サウジアラビア） ・企業情報 Bayer Healthcare、Vetoquinol S.A、Boehringer Ingelheim、Ceva、Eli Lilly、Heska Co.、Merck Animal Health、Merial (Sanofi)、Virbac、Zoetis (Pfizer) ・産業チェーン及び販売チャネル分析 - ペット用ワクチンの産業チェーン分析 - ペット用ワクチンの原材料 - ペット用ワクチンの生産プロセス - ペット用ワクチンの販売及びマーケティング - ペット用ワクチンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ペット用ワクチンの産業動向 - ペット用ワクチンのマーケットドライバー - ペット用ワクチンの課題 - ペット用ワクチンの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Pet Vaccine Market
Due to the COVID-19 pandemic, the global Pet Vaccine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Attenuated Live Vaccines accounting for % of the Pet Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Canine segment is altered to an % CAGR throughout this forecast period.
China Pet Vaccine market size is valued at US$ million in 2021, while the US and Europe Pet Vaccine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pet Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Pet Vaccine include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska Co., Merck Animal Health, Merial (Sanofi) and Virbac and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Pet Vaccine Scope and Segment
Pet Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pet Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Segment by Application
Canine
Avian
Feline
By Company
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Pet Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pet Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Pet Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pet Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Pet Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Pet Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pet Vaccine Sales by Region
2.4.1 Global Pet Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Pet Vaccine by Region (2023-2028)
2.5 Global Pet Vaccine Revenue by Region
2.5.1 Global Pet Vaccine Revenue by Region (2017-2022)
2.5.2 Global Pet Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pet Vaccine Sales by Manufacturers
3.1.1 Global Top Pet Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Pet Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet Vaccine in 2021
3.2 Global Pet Vaccine Revenue by Manufacturers
3.2.1 Global Pet Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Pet Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pet Vaccine Revenue in 2021
3.3 Global Pet Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pet Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet Vaccine Sales by Type
4.1.1 Global Pet Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Pet Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Pet Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Pet Vaccine Revenue by Type
4.2.1 Global Pet Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Pet Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pet Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Pet Vaccine Price by Type
4.3.1 Global Pet Vaccine Price by Type (2017-2022)
4.3.2 Global Pet Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pet Vaccine Sales by Application
5.1.1 Global Pet Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Pet Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Pet Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Pet Vaccine Revenue by Application
5.2.1 Global Pet Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Pet Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pet Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Pet Vaccine Price by Application
5.3.1 Global Pet Vaccine Price by Application (2017-2022)
5.3.2 Global Pet Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pet Vaccine Market Size by Type
6.1.1 North America Pet Vaccine Sales by Type (2017-2028)
6.1.2 North America Pet Vaccine Revenue by Type (2017-2028)
6.2 North America Pet Vaccine Market Size by Application
6.2.1 North America Pet Vaccine Sales by Application (2017-2028)
6.2.2 North America Pet Vaccine Revenue by Application (2017-2028)
6.3 North America Pet Vaccine Market Size by Country
6.3.1 North America Pet Vaccine Sales by Country (2017-2028)
6.3.2 North America Pet Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pet Vaccine Market Size by Type
7.1.1 Europe Pet Vaccine Sales by Type (2017-2028)
7.1.2 Europe Pet Vaccine Revenue by Type (2017-2028)
7.2 Europe Pet Vaccine Market Size by Application
7.2.1 Europe Pet Vaccine Sales by Application (2017-2028)
7.2.2 Europe Pet Vaccine Revenue by Application (2017-2028)
7.3 Europe Pet Vaccine Market Size by Country
7.3.1 Europe Pet Vaccine Sales by Country (2017-2028)
7.3.2 Europe Pet Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pet Vaccine Market Size by Type
8.1.1 Asia Pacific Pet Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Pet Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Pet Vaccine Market Size by Application
8.2.1 Asia Pacific Pet Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Pet Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Pet Vaccine Market Size by Region
8.3.1 Asia Pacific Pet Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Pet Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pet Vaccine Market Size by Type
9.1.1 Latin America Pet Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Pet Vaccine Revenue by Type (2017-2028)
9.2 Latin America Pet Vaccine Market Size by Application
9.2.1 Latin America Pet Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Pet Vaccine Revenue by Application (2017-2028)
9.3 Latin America Pet Vaccine Market Size by Country
9.3.1 Latin America Pet Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Pet Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pet Vaccine Market Size by Type
10.1.1 Middle East and Africa Pet Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pet Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Pet Vaccine Market Size by Application
10.2.1 Middle East and Africa Pet Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pet Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Pet Vaccine Market Size by Country
10.3.1 Middle East and Africa Pet Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pet Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Healthcare Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Healthcare Recent Developments
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Corporation Information
11.2.2 Vetoquinol S.A Overview
11.2.3 Vetoquinol S.A Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vetoquinol S.A Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol S.A Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Corporation Information
11.4.2 Ceva Overview
11.4.3 Ceva Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ceva Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 Heska Co.
11.6.1 Heska Co. Corporation Information
11.6.2 Heska Co. Overview
11.6.3 Heska Co. Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Heska Co. Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heska Co. Recent Developments
11.7 Merck Animal Health
11.7.1 Merck Animal Health Corporation Information
11.7.2 Merck Animal Health Overview
11.7.3 Merck Animal Health Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Animal Health Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Animal Health Recent Developments
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Corporation Information
11.8.2 Merial (Sanofi) Overview
11.8.3 Merial (Sanofi) Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merial (Sanofi) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial (Sanofi) Recent Developments
11.9 Virbac
11.9.1 Virbac Corporation Information
11.9.2 Virbac Overview
11.9.3 Virbac Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Virbac Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Virbac Recent Developments
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Corporation Information
11.10.2 Zoetis (Pfizer) Overview
11.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zoetis (Pfizer) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zoetis (Pfizer) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet Vaccine Industry Chain Analysis
12.2 Pet Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet Vaccine Production Mode & Process
12.4 Pet Vaccine Sales and Marketing
12.4.1 Pet Vaccine Sales Channels
12.4.2 Pet Vaccine Distributors
12.5 Pet Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pet Vaccine Industry Trends
13.2 Pet Vaccine Market Drivers
13.3 Pet Vaccine Market Challenges
13.4 Pet Vaccine Market Restraints
14 Key Findings in The Global Pet Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Pet Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Attenuated Live Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Inactivated Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of DNA Vaccines
Table 8. Major Manufacturers of Recombinant Vaccines
Table 9. Global Pet Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Pet Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 12. Global Pet Vaccine Sales Market Share by Region (2017-2022)
Table 13. Global Pet Vaccine Sales by Region (2023-2028) & (K Doses)
Table 14. Global Pet Vaccine Sales Market Share by Region (2023-2028)
Table 15. Global Pet Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Pet Vaccine Revenue Market Share by Region (2017-2022)
Table 17. Global Pet Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Pet Vaccine Revenue Market Share by Region (2023-2028)
Table 19. Global Pet Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
Table 20. Global Pet Vaccine Sales Share by Manufacturers (2017-2022)
Table 21. Global Pet Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Pet Vaccine Revenue Share by Manufacturers (2017-2022)
Table 23. Pet Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
Table 24. Global Pet Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pet Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Vaccine as of 2021)
Table 26. Pet Vaccine Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Pet Vaccine Product Offered
Table 28. Date of Manufacturers Enter into Pet Vaccine Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 31. Global Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 32. Global Pet Vaccine Sales Share by Type (2017-2022)
Table 33. Global Pet Vaccine Sales Share by Type (2023-2028)
Table 34. Global Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Pet Vaccine Revenue Share by Type (2017-2022)
Table 37. Global Pet Vaccine Revenue Share by Type (2023-2028)
Table 38. Pet Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 39. Global Pet Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
Table 40. Global Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 41. Global Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 42. Global Pet Vaccine Sales Share by Application (2017-2022)
Table 43. Global Pet Vaccine Sales Share by Application (2023-2028)
Table 44. Global Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Pet Vaccine Revenue Share by Application (2017-2022)
Table 47. Global Pet Vaccine Revenue Share by Application (2023-2028)
Table 48. Pet Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 49. Global Pet Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
Table 50. North America Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 51. North America Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 52. North America Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 55. North America Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 56. North America Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 59. North America Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 60. North America Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Pet Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 63. Europe Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 64. Europe Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 67. Europe Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 68. Europe Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 71. Europe Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 72. Europe Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Pet Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 75. Asia Pacific Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 76. Asia Pacific Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 79. Asia Pacific Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 80. Asia Pacific Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 83. Asia Pacific Pet Vaccine Sales by Region (2023-2028) & (K Doses)
Table 84. Asia Pacific Pet Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Pet Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 87. Latin America Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 88. Latin America Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 91. Latin America Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 92. Latin America Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 95. Latin America Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 96. Latin America Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Pet Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 99. Middle East and Africa Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 100. Middle East and Africa Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 103. Middle East and Africa Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 104. Middle East and Africa Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 107. Middle East and Africa Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 108. Middle East and Africa Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Pet Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 110. Bayer Healthcare Corporation Information
Table 111. Bayer Healthcare Description and Major Businesses
Table 112. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Bayer Healthcare Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer Healthcare Recent Developments
Table 115. Vetoquinol S.A Corporation Information
Table 116. Vetoquinol S.A Description and Major Businesses
Table 117. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Vetoquinol S.A Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Vetoquinol S.A Recent Developments
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Boehringer Ingelheim Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Ceva Corporation Information
Table 126. Ceva Description and Major Businesses
Table 127. Ceva Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Ceva Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Ceva Recent Developments
Table 130. Eli Lilly Corporation Information
Table 131. Eli Lilly Description and Major Businesses
Table 132. Eli Lilly Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Eli Lilly Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Eli Lilly Recent Developments
Table 135. Heska Co. Corporation Information
Table 136. Heska Co. Description and Major Businesses
Table 137. Heska Co. Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Heska Co. Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Heska Co. Recent Developments
Table 140. Merck Animal Health Corporation Information
Table 141. Merck Animal Health Description and Major Businesses
Table 142. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Merck Animal Health Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Merck Animal Health Recent Developments
Table 145. Merial (Sanofi) Corporation Information
Table 146. Merial (Sanofi) Description and Major Businesses
Table 147. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Merial (Sanofi) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merial (Sanofi) Recent Developments
Table 150. Virbac Corporation Information
Table 151. Virbac Description and Major Businesses
Table 152. Virbac Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. Virbac Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Virbac Recent Developments
Table 155. Zoetis (Pfizer) Corporation Information
Table 156. Zoetis (Pfizer) Description and Major Businesses
Table 157. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. Zoetis (Pfizer) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Zoetis (Pfizer) Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Pet Vaccine Distributors List
Table 163. Pet Vaccine Customers List
Table 164. Pet Vaccine Market Trends
Table 165. Pet Vaccine Market Drivers
Table 166. Pet Vaccine Market Challenges
Table 167. Pet Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Vaccine Product Picture
Figure 3. Global Pet Vaccine Market Share by Type in 2021 & 2028
Figure 3. Attenuated Live Vaccines Product Picture
Figure 4. Conjugate Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Toxoid Vaccines Product Picture
Figure 8. DNA Vaccines Product Picture
Figure 9. Recombinant Vaccines Product Picture
Figure 10. Global Pet Vaccine Market Share by Application in 2021 & 2028
Figure 11. Canine
Figure 12. Avian
Figure 13. Feline
Figure 14. Pet Vaccine Report Years Considered
Figure 15. Global Pet Vaccine Sales 2017-2028 (K Doses)
Figure 16. Global Pet Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Pet Vaccine Revenue 2017-2028 (US$ Million)
Figure 18. Global Pet Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Pet Vaccine Sales Market Share by Region (2017-2022)
Figure 20. Global Pet Vaccine Sales Market Share by Region (2023-2028)
Figure 21. North America Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 22. North America Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 24. Europe Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 26. Asia-Pacific Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 28. Latin America Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 30. Middle East & Africa Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Pet Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Pet Vaccine in the World: Market Share by Pet Vaccine Revenue in 2021
Figure 33. Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 35. Global Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. Global Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 37. Global Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. North America Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 39. North America Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 40. North America Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 41. North America Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 42. North America Pet Vaccine Sales Share by Country (2017-2028)
Figure 43. North America Pet Vaccine Revenue Share by Country (2017-2028)
Figure 44. U.S. Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 47. Europe Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 48. Europe Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 49. Europe Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 50. Europe Pet Vaccine Sales Share by Country (2017-2028)
Figure 51. Europe Pet Vaccine Revenue Share by Country (2017-2028)
Figure 52. Germany Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. France Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Pet Vaccine Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Pet Vaccine Revenue Share by Region (2017-2028)
Figure 63. China Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. India Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 74. Latin America Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 76. Latin America Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Pet Vaccine Sales Share by Country (2017-2028)
Figure 78. Latin America Pet Vaccine Revenue Share by Country (2017-2028)
Figure 79. Mexico Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Pet Vaccine Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Pet Vaccine Revenue Share by Country (2017-2028)
Figure 88. Turkey Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 91. Pet Vaccine Value Chain
Figure 92. Pet Vaccine Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

---